Hypertrophic response of Duchenne and limb-girdle muscular dystrophies is associated with activation of Akt pathway.
about
Enhancing muscle membrane repair by gene delivery of MG53 ameliorates muscular dystrophy and heart failure in δ-Sarcoglycan-deficient hamsters.Reduced IGF signaling prevents muscle cell death in a Caenorhabditis elegans model of muscular dystrophyMuscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy.Dystrophin glycoprotein complex-associated Gbetagamma subunits activate phosphatidylinositol-3-kinase/Akt signaling in skeletal muscle in a laminin-dependent manner.Therapeutic targeting of signaling pathways in muscular dystrophy.Skeletal muscle homeostasis in duchenne muscular dystrophy: modulating autophagy as a promising therapeutic strategy.The different impact of a high fat diet on dystrophic mdx and control C57Bl/10 miceSarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration.Sarcospan integration into laminin-binding adhesion complexes that ameliorate muscular dystrophy requires utrophin and α7 integrin.Myogenic Akt signaling attenuates muscular degeneration, promotes myofiber regeneration and improves muscle function in dystrophin-deficient mdx mice.Sarcospan reduces dystrophic pathology: stabilization of the utrophin-glycoprotein complex.Elevated levels of active matrix metalloproteinase-9 cause hypertrophy in skeletal muscle of normal and dystrophin-deficient mdx mice.Genetic deletion of trkB.T1 increases neuromuscular function.Molecular and cellular mechanisms of skeletal muscle atrophy: an update.Dystrophin and utrophin expression require sarcospan: loss of α7 integrin exacerbates a newly discovered muscle phenotype in sarcospan-null mice.Processing and assembly of the dystrophin glycoprotein complex.Sarcospan Regulates Cardiac Isoproterenol Response and Prevents Duchenne Muscular Dystrophy-Associated CardiomyopathyMyogenic Akt signaling upregulates the utrophin-glycoprotein complex and promotes sarcolemma stability in muscular dystrophy.Increased sphingosine-1-phosphate improves muscle regeneration in acutely injured mdx mice.Wasting mechanisms in muscular dystrophy.PTEN contributes to profound PI3K/Akt signaling pathway deregulation in dystrophin-deficient dog muscle.Distinct roles of TRAF6 at early and late stages of muscle pathology in the mdx model of Duchenne muscular dystrophy."Get the Balance Right": Pathological Significance of Autophagy Perturbation in Neuromuscular DisordersThe paradox of muscle hypertrophy in muscular dystrophy.What do mouse models of muscular dystrophy tell us about the DAPC and its components?Autophagy as a new therapeutic target in Duchenne muscular dystrophyMuscular dystrophy in PTFR/cavin-1 null mice.Activation of AKT signaling promotes cell growth and survival in α7β1 integrin-mediated alleviation of muscular dystrophy.Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.Autophagic dysfunction and autophagosome escape in the mdx mus musculus model of Duchenne muscular dystrophy.
P2860
Q30512833-2309FA9B-9EC2-450B-8252-56C767EE7022Q30557792-20D56AD8-9912-4628-A8F3-E517C9D0D27CQ33589972-BFA80DF9-186B-4F2F-B1CE-BF0885B60FF8Q33648785-5D250DC0-302C-4529-9695-6F43079CF74BQ33707964-EBA5844F-C522-40B3-8F4B-7335FE4B1AF5Q33944130-431525FC-0ED4-4D74-A86F-0D9F449DA4E1Q34077151-2C0E77B6-B016-493D-B014-EAFDFCB25B04Q34284175-B5105A41-856C-490E-81F6-FA72545EC085Q34453676-527D82B1-ABA6-46B5-86CF-3599CCDBA5F1Q34627033-6B31F90F-CE49-452D-9196-C32BC2698876Q34871548-DECEF5B9-644B-4D02-BEB5-0838CCDCD225Q35389391-D7C164EF-999D-466A-85DD-E24D1ABD7412Q35895736-F47107D3-B7DB-4676-B0B2-70FDC61C5D49Q36179105-079CBB20-A896-46E5-BCD9-E29796E221BAQ36283349-8E6A19C5-4B66-4CD3-A748-B9D0D7445DA0Q36726710-0B213253-D065-4BB3-8A18-D2E5F78C6903Q36836386-F0B9FD4E-E72F-447F-AFD0-1EF5D68399F3Q37089991-6AC13EAB-99BD-4F0F-AACF-ECAC5063188CQ37114072-C149EF17-D525-4C21-B7D7-4039490535C8Q37138490-C3FCC2FF-7DA9-4774-BC44-18488617D028Q37164566-B89F5D14-15E9-4D45-9A60-6B8CA42FAE6BQ37593034-56DB1013-FCA0-4776-AE65-891615346F3CQ37610585-B9E913F0-E2EB-4FFF-98C9-BA1457A427DAQ37975319-AD76EC88-8A6E-4420-95F1-8F8DAED80850Q38255744-7A498B14-F7C1-4EC3-BB57-6EFBDAD27C08Q41869455-CBE39012-C8A1-4C4D-A78B-44195ABCFE2BQ42318817-0B6B464E-4E09-4FEB-BCDF-5A506A33360FQ42639922-66FB8129-D95C-41E2-85EE-BDC1D0DB737DQ45781418-41263EA8-DABE-4808-9A75-E940FCC7F9C1Q47915335-F97BDEA6-12A2-444C-9C44-135B702E2299
P2860
Hypertrophic response of Duchenne and limb-girdle muscular dystrophies is associated with activation of Akt pathway.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Hypertrophic response of Duche ...... ith activation of Akt pathway.
@en
Hypertrophic response of Duche ...... ith activation of Akt pathway.
@nl
type
label
Hypertrophic response of Duche ...... ith activation of Akt pathway.
@en
Hypertrophic response of Duche ...... ith activation of Akt pathway.
@nl
prefLabel
Hypertrophic response of Duche ...... ith activation of Akt pathway.
@en
Hypertrophic response of Duche ...... ith activation of Akt pathway.
@nl
P1476
Hypertrophic response of Duche ...... ith activation of Akt pathway.
@en
P2093
Angela K Peter
Rachelle H Crosbie
P304
P356
10.1016/J.YEXCR.2006.04.024
P407
P577
2006-05-22T00:00:00Z